Eosinophilic chronic rhinosinusitis (ECRS) is a type of airway disease that involves nasal inflammation. Here, semaphorin protein was found to contribute to allergic reactions and development of nasal polyps in patients with ECRS. A research team found that an anti-semaphorin antibody could reduce nasal inflammation in a mouse model of ECRS and that semaphorin protein could be a new biomarker for ECRS in patients with nasal inflammation.
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024Metronidazole for bacterial infection
February 1, 2023